Mesoblast Limited (MSB)
24.44
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 6-K MESOBLAST LTD For: Jun 10
June 10, 2026 8:51 AM - SEC Filing
Form 8-K MESABI TRUST For: Apr 30
May 4, 2026 4:31 PM - SEC Filing
Mesabi Trust Press Release
May 4, 2026 4:05 PM - BizWire
Form 6-K MESOBLAST LTD For: Apr 30
April 30, 2026 7:56 AM - SEC Filing
Form SCHEDULE 13G/A MESABI TRUST Filed by: HORIZON KINETICS ASSET MANAGEMENT LLC
April 29, 2026 1:53 PM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: COBLEY LYNETTE ELIZABETH
April 29, 2026 6:10 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 29
April 29, 2026 6:10 AM - SEC Filing
Mesoblast completes patient recruitment for phase 3 chronic back pain trial
April 28, 2026 8:53 PM - StreetInsider
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
April 28, 2026 8:53 PM - Globe NewsWire
Form ARS MESABI TRUST For: Jan 31
April 22, 2026 4:40 PM - SEC Filing
Form 10-K MESABI TRUST For: Jan 31
April 22, 2026 4:32 PM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 17
April 17, 2026 6:06 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 15
April 15, 2026 9:11 AM - SEC Filing
Mesoblast acquires CAR platform technology to enhance cell therapies
April 14, 2026 8:11 PM - StreetInsider
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
April 14, 2026 8:11 PM - Globe NewsWire
Form 8-K MESABI TRUST For: Apr 14
April 14, 2026 4:30 PM - SEC Filing
Mesabi Trust Press Release
April 14, 2026 4:05 PM - BizWire
Form 4 MESOBLAST LTD For: Apr 09 Filed by: George Gregory
April 13, 2026 7:20 AM - SEC Filing
Form 4 MESOBLAST LTD For: Apr 09 Filed by: George Gregory
April 10, 2026 7:28 PM - SEC Filing
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
April 10, 2026 4:09 PM - Globe NewsWire
Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
April 8, 2026 9:07 AM - Globe NewsWire
Form 6-K MESOBLAST LTD For: Apr 08
April 8, 2026 7:19 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 08
April 8, 2026 6:19 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 08
April 8, 2026 6:17 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Apr 08
April 8, 2026 6:15 AM - SEC Filing
Mesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy
April 7, 2026 11:35 PM - Globe NewsWire
Form 3 MESOBLAST LTD For: Mar 18 Filed by: BURNS WILLIAM MURRAY
April 1, 2026 6:26 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: Itescu Silviu
April 1, 2026 6:25 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: Itescu Silviu
April 1, 2026 6:24 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: George Gregory
March 23, 2026 8:00 PM - SEC Filing
Form 6-K MESOBLAST LTD For: Mar 23
March 23, 2026 7:52 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: KRAUSE PHILIP R.
March 18, 2026 5:45 PM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: FACCHINA PHILIP JAMES
March 18, 2026 9:41 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: BELL JANE CATHERINE
March 18, 2026 9:40 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: OBRIEN JAMES MICHAEL
March 18, 2026 9:35 AM - SEC Filing
Form 3 MESOBLAST LTD For: Mar 18 Filed by: ROSE ERIC ALLEN
March 18, 2026 9:34 AM - SEC Filing
Form 6-K MESOBLAST LTD For: Mar 18
March 18, 2026 6:54 AM - SEC Filing
Mesoblast to Host R&D Day on April 8, 2026
March 17, 2026 7:19 PM - Globe NewsWire
Form 3 MESOBLAST LTD For: Mar 16 Filed by: George Gregory
March 16, 2026 6:07 PM - SEC Filing
Form 6-K MESOBLAST LTD For: Mar 12
March 13, 2026 6:08 AM - SEC Filing
Full Article List
